HEPION PHARMACEUTICALS INC (HEPA) Stock News

USA - NASDAQ:HEPA - US4268974015 - Common Stock

0.318 USD

-0.07 (-18.79%)

Last: 5/12/2025, 8:00:01 PM

0.1748 USD

-0.14 (-45.03%)

After Hours: 5/12/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

HEPA Latest News, Press Relases and Analysis

All

Press Releases

5 months ago - By: Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals Successfully Completes Application to the OTCQB

5 months ago - By: Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer

6 months ago - By: Stocktwits

Hepion Pharma Stock Draws Bullish Retail Bets Despite Nasdaq Delisting Notice: 'Could Get Interesting'

6 months ago - By: Benzinga - Mentions: HBIO SGMO OPRX AXDX ...

12 Health Care Stocks Moving In Monday's After-Market Session

6 months ago - By: Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq

6 months ago - By: Yahoo Finance - Mentions: KRYS JAZZ TECH BOLT

Biotech Alert: Searches spiking for these stocks today

6 months ago - By: Benzinga - Mentions: PTN HALO MYGN AGL ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

6 months ago - By: Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC

8 months ago - By: Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals Announces Reverse Stock Split